nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—UGT1A1—Etoposide—germ cell cancer	0.31	0.476	CbGbCtD
Naltrexone—ABCB1—Dactinomycin—germ cell cancer	0.109	0.167	CbGbCtD
Naltrexone—ABCB1—Vinblastine—germ cell cancer	0.0683	0.105	CbGbCtD
Naltrexone—ABCB1—Cisplatin—germ cell cancer	0.0626	0.096	CbGbCtD
Naltrexone—ABCB1—Etoposide—germ cell cancer	0.0615	0.0943	CbGbCtD
Naltrexone—ABCB1—Methotrexate—germ cell cancer	0.0407	0.0623	CbGbCtD
Naltrexone—UGT1A1—urine—germ cell cancer	0.00865	0.149	CbGeAlD
Naltrexone—OPRM1—telencephalic ventricle—germ cell cancer	0.00745	0.128	CbGeAlD
Naltrexone—OPRD1—ganglion—germ cell cancer	0.0068	0.117	CbGeAlD
Naltrexone—OPRM1—ganglion—germ cell cancer	0.00464	0.0798	CbGeAlD
Naltrexone—OPRD1—telencephalon—germ cell cancer	0.00262	0.0452	CbGeAlD
Naltrexone—OPRM1—brainstem—germ cell cancer	0.00202	0.0347	CbGeAlD
Naltrexone—OPRM1—telencephalon—germ cell cancer	0.00179	0.0308	CbGeAlD
Naltrexone—OPRD1—head—germ cell cancer	0.00163	0.0281	CbGeAlD
Naltrexone—OPRK1—head—germ cell cancer	0.00157	0.027	CbGeAlD
Naltrexone—UGT1A1—endocrine gland—germ cell cancer	0.00143	0.0247	CbGeAlD
Naltrexone—OPRK1—cerebellum—germ cell cancer	0.0014	0.024	CbGeAlD
Naltrexone—OPRM1—midbrain—germ cell cancer	0.00129	0.0221	CbGeAlD
Naltrexone—OPRM1—spinal cord—germ cell cancer	0.00125	0.0216	CbGeAlD
Naltrexone—OPRD1—brain—germ cell cancer	0.00118	0.0204	CbGeAlD
Naltrexone—OPRK1—brain—germ cell cancer	0.00114	0.0195	CbGeAlD
Naltrexone—OPRM1—endocrine gland—germ cell cancer	0.00113	0.0194	CbGeAlD
Naltrexone—OPRM1—head—germ cell cancer	0.00111	0.0192	CbGeAlD
Naltrexone—OPRM1—testis—germ cell cancer	0.00108	0.0185	CbGeAlD
Naltrexone—ABCB1—blood vessel—germ cell cancer	0.00106	0.0183	CbGeAlD
Naltrexone—OPRM1—brain—germ cell cancer	0.000808	0.0139	CbGeAlD
Naltrexone—Anaphylactic shock—Bleomycin—germ cell cancer	0.000705	0.00244	CcSEcCtD
Naltrexone—Oedema—Bleomycin—germ cell cancer	0.000705	0.00244	CcSEcCtD
Naltrexone—Infection—Bleomycin—germ cell cancer	0.000701	0.00242	CcSEcCtD
Naltrexone—Vision blurred—Ifosfamide—germ cell cancer	0.000696	0.00241	CcSEcCtD
Naltrexone—Feeling abnormal—Vinblastine—germ cell cancer	0.000688	0.00238	CcSEcCtD
Naltrexone—Myalgia—Dactinomycin—germ cell cancer	0.000686	0.00237	CcSEcCtD
Naltrexone—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000685	0.00237	CcSEcCtD
Naltrexone—Eye disorder—Cisplatin—germ cell cancer	0.000684	0.00236	CcSEcCtD
Naltrexone—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000683	0.00236	CcSEcCtD
Naltrexone—Tinnitus—Cisplatin—germ cell cancer	0.000682	0.00236	CcSEcCtD
Naltrexone—Lymphadenopathy—Methotrexate—germ cell cancer	0.00068	0.00235	CcSEcCtD
Naltrexone—Cardiac disorder—Cisplatin—germ cell cancer	0.000679	0.00235	CcSEcCtD
Naltrexone—Agitation—Ifosfamide—germ cell cancer	0.000679	0.00235	CcSEcCtD
Naltrexone—Discomfort—Dactinomycin—germ cell cancer	0.000678	0.00234	CcSEcCtD
Naltrexone—Angioedema—Ifosfamide—germ cell cancer	0.000675	0.00233	CcSEcCtD
Naltrexone—Anorexia—Bleomycin—germ cell cancer	0.000672	0.00232	CcSEcCtD
Naltrexone—Malaise—Ifosfamide—germ cell cancer	0.000666	0.0023	CcSEcCtD
Naltrexone—Immune system disorder—Cisplatin—germ cell cancer	0.000661	0.00228	CcSEcCtD
Naltrexone—Abdominal pain—Vinblastine—germ cell cancer	0.00066	0.00228	CcSEcCtD
Naltrexone—Mediastinal disorder—Cisplatin—germ cell cancer	0.000659	0.00228	CcSEcCtD
Naltrexone—Oedema—Dactinomycin—germ cell cancer	0.000658	0.00227	CcSEcCtD
Naltrexone—ABCB1—trigeminal ganglion—germ cell cancer	0.000657	0.0113	CbGeAlD
Naltrexone—Infection—Dactinomycin—germ cell cancer	0.000653	0.00226	CcSEcCtD
Naltrexone—Palpitations—Ifosfamide—germ cell cancer	0.000653	0.00226	CcSEcCtD
Naltrexone—Alopecia—Cisplatin—germ cell cancer	0.000646	0.00223	CcSEcCtD
Naltrexone—Cough—Ifosfamide—germ cell cancer	0.000644	0.00223	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000643	0.00222	CcSEcCtD
Naltrexone—Convulsion—Ifosfamide—germ cell cancer	0.00064	0.00221	CcSEcCtD
Naltrexone—Hypertension—Ifosfamide—germ cell cancer	0.000638	0.0022	CcSEcCtD
Naltrexone—Malnutrition—Cisplatin—germ cell cancer	0.000637	0.0022	CcSEcCtD
Naltrexone—ABCB1—embryo—germ cell cancer	0.000635	0.0109	CbGeAlD
Naltrexone—Paraesthesia—Bleomycin—germ cell cancer	0.000633	0.00219	CcSEcCtD
Naltrexone—Dyspnoea—Bleomycin—germ cell cancer	0.000629	0.00217	CcSEcCtD
Naltrexone—Myalgia—Ifosfamide—germ cell cancer	0.000629	0.00217	CcSEcCtD
Naltrexone—Chest pain—Ifosfamide—germ cell cancer	0.000629	0.00217	CcSEcCtD
Naltrexone—Arthralgia—Ifosfamide—germ cell cancer	0.000629	0.00217	CcSEcCtD
Naltrexone—Flatulence—Cisplatin—germ cell cancer	0.000627	0.00217	CcSEcCtD
Naltrexone—Anorexia—Dactinomycin—germ cell cancer	0.000627	0.00217	CcSEcCtD
Naltrexone—Eye disorder—Etoposide—germ cell cancer	0.000626	0.00217	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000624	0.00216	CcSEcCtD
Naltrexone—Cardiac disorder—Etoposide—germ cell cancer	0.000622	0.00215	CcSEcCtD
Naltrexone—Discomfort—Ifosfamide—germ cell cancer	0.000621	0.00215	CcSEcCtD
Naltrexone—Hypersensitivity—Vinblastine—germ cell cancer	0.000615	0.00213	CcSEcCtD
Naltrexone—Decreased appetite—Bleomycin—germ cell cancer	0.000613	0.00212	CcSEcCtD
Naltrexone—Muscle spasms—Cisplatin—germ cell cancer	0.000612	0.00212	CcSEcCtD
Naltrexone—Angiopathy—Etoposide—germ cell cancer	0.000608	0.0021	CcSEcCtD
Naltrexone—Confusional state—Ifosfamide—germ cell cancer	0.000608	0.0021	CcSEcCtD
Naltrexone—Immune system disorder—Etoposide—germ cell cancer	0.000605	0.00209	CcSEcCtD
Naltrexone—Mediastinal disorder—Etoposide—germ cell cancer	0.000604	0.00209	CcSEcCtD
Naltrexone—Pain—Bleomycin—germ cell cancer	0.000603	0.00209	CcSEcCtD
Naltrexone—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000603	0.00208	CcSEcCtD
Naltrexone—Oedema—Ifosfamide—germ cell cancer	0.000603	0.00208	CcSEcCtD
Naltrexone—Chills—Etoposide—germ cell cancer	0.000601	0.00208	CcSEcCtD
Naltrexone—Vision blurred—Cisplatin—germ cell cancer	0.0006	0.00207	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000599	0.00207	CcSEcCtD
Naltrexone—Asthenia—Vinblastine—germ cell cancer	0.000599	0.00207	CcSEcCtD
Naltrexone—Infection—Ifosfamide—germ cell cancer	0.000599	0.00207	CcSEcCtD
Naltrexone—Tremor—Cisplatin—germ cell cancer	0.000597	0.00206	CcSEcCtD
Naltrexone—Alopecia—Etoposide—germ cell cancer	0.000592	0.00205	CcSEcCtD
Naltrexone—Lethargy—Methotrexate—germ cell cancer	0.000592	0.00205	CcSEcCtD
Naltrexone—Nervous system disorder—Ifosfamide—germ cell cancer	0.000591	0.00204	CcSEcCtD
Naltrexone—Ill-defined disorder—Cisplatin—germ cell cancer	0.000591	0.00204	CcSEcCtD
Naltrexone—Skin disorder—Ifosfamide—germ cell cancer	0.000585	0.00202	CcSEcCtD
Naltrexone—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000583	0.00201	CcSEcCtD
Naltrexone—Feeling abnormal—Bleomycin—germ cell cancer	0.000581	0.00201	CcSEcCtD
Naltrexone—Anorexia—Ifosfamide—germ cell cancer	0.000575	0.00199	CcSEcCtD
Naltrexone—Malaise—Cisplatin—germ cell cancer	0.000574	0.00199	CcSEcCtD
Naltrexone—Decreased appetite—Dactinomycin—germ cell cancer	0.000572	0.00198	CcSEcCtD
Naltrexone—Diarrhoea—Vinblastine—germ cell cancer	0.000571	0.00198	CcSEcCtD
Naltrexone—Dysgeusia—Etoposide—germ cell cancer	0.000571	0.00197	CcSEcCtD
Naltrexone—Fatigue—Dactinomycin—germ cell cancer	0.000567	0.00196	CcSEcCtD
Naltrexone—Back pain—Etoposide—germ cell cancer	0.000564	0.00195	CcSEcCtD
Naltrexone—Pain—Dactinomycin—germ cell cancer	0.000562	0.00194	CcSEcCtD
Naltrexone—ABCB1—retina—germ cell cancer	0.000561	0.00965	CbGeAlD
Naltrexone—Muscle spasms—Etoposide—germ cell cancer	0.000561	0.00194	CcSEcCtD
Naltrexone—Urticaria—Bleomycin—germ cell cancer	0.00056	0.00194	CcSEcCtD
Naltrexone—Body temperature increased—Bleomycin—germ cell cancer	0.000558	0.00193	CcSEcCtD
Naltrexone—Irritability—Methotrexate—germ cell cancer	0.000554	0.00191	CcSEcCtD
Naltrexone—Dizziness—Vinblastine—germ cell cancer	0.000552	0.00191	CcSEcCtD
Naltrexone—Convulsion—Cisplatin—germ cell cancer	0.000552	0.00191	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000549	0.0019	CcSEcCtD
Naltrexone—Myalgia—Cisplatin—germ cell cancer	0.000542	0.00187	CcSEcCtD
Naltrexone—Feeling abnormal—Dactinomycin—germ cell cancer	0.000542	0.00187	CcSEcCtD
Naltrexone—Paraesthesia—Ifosfamide—germ cell cancer	0.000541	0.00187	CcSEcCtD
Naltrexone—Ill-defined disorder—Etoposide—germ cell cancer	0.000541	0.00187	CcSEcCtD
Naltrexone—Anxiety—Cisplatin—germ cell cancer	0.00054	0.00187	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000538	0.00186	CcSEcCtD
Naltrexone—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000538	0.00186	CcSEcCtD
Naltrexone—Dyspnoea—Ifosfamide—germ cell cancer	0.000537	0.00186	CcSEcCtD
Naltrexone—Somnolence—Ifosfamide—germ cell cancer	0.000536	0.00185	CcSEcCtD
Naltrexone—Discomfort—Cisplatin—germ cell cancer	0.000536	0.00185	CcSEcCtD
Naltrexone—Vomiting—Vinblastine—germ cell cancer	0.000531	0.00184	CcSEcCtD
Naltrexone—Malaise—Etoposide—germ cell cancer	0.000526	0.00182	CcSEcCtD
Naltrexone—Decreased appetite—Ifosfamide—germ cell cancer	0.000524	0.00181	CcSEcCtD
Naltrexone—Headache—Vinblastine—germ cell cancer	0.000523	0.00181	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00052	0.0018	CcSEcCtD
Naltrexone—Body temperature increased—Dactinomycin—germ cell cancer	0.00052	0.0018	CcSEcCtD
Naltrexone—Abdominal pain—Dactinomycin—germ cell cancer	0.00052	0.0018	CcSEcCtD
Naltrexone—Fatigue—Ifosfamide—germ cell cancer	0.00052	0.0018	CcSEcCtD
Naltrexone—Oedema—Cisplatin—germ cell cancer	0.00052	0.0018	CcSEcCtD
Naltrexone—Anaphylactic shock—Cisplatin—germ cell cancer	0.00052	0.0018	CcSEcCtD
Naltrexone—Hypersensitivity—Bleomycin—germ cell cancer	0.00052	0.0018	CcSEcCtD
Naltrexone—Infection—Cisplatin—germ cell cancer	0.000516	0.00178	CcSEcCtD
Naltrexone—ABCB1—telencephalon—germ cell cancer	0.000516	0.00888	CbGeAlD
Naltrexone—Pain—Ifosfamide—germ cell cancer	0.000515	0.00178	CcSEcCtD
Naltrexone—Constipation—Ifosfamide—germ cell cancer	0.000515	0.00178	CcSEcCtD
Naltrexone—Loss of consciousness—Etoposide—germ cell cancer	0.000513	0.00177	CcSEcCtD
Naltrexone—Nervous system disorder—Cisplatin—germ cell cancer	0.00051	0.00176	CcSEcCtD
Naltrexone—Cough—Etoposide—germ cell cancer	0.000509	0.00176	CcSEcCtD
Naltrexone—Tachycardia—Cisplatin—germ cell cancer	0.000507	0.00175	CcSEcCtD
Naltrexone—Asthenia—Bleomycin—germ cell cancer	0.000506	0.00175	CcSEcCtD
Naltrexone—Convulsion—Etoposide—germ cell cancer	0.000505	0.00175	CcSEcCtD
Naltrexone—Skin disorder—Cisplatin—germ cell cancer	0.000505	0.00175	CcSEcCtD
Naltrexone—Hypertension—Etoposide—germ cell cancer	0.000504	0.00174	CcSEcCtD
Naltrexone—Hyperhidrosis—Cisplatin—germ cell cancer	0.000502	0.00174	CcSEcCtD
Naltrexone—Pruritus—Bleomycin—germ cell cancer	0.000499	0.00173	CcSEcCtD
Naltrexone—Feeling abnormal—Ifosfamide—germ cell cancer	0.000497	0.00172	CcSEcCtD
Naltrexone—Chest pain—Etoposide—germ cell cancer	0.000497	0.00172	CcSEcCtD
Naltrexone—Nausea—Vinblastine—germ cell cancer	0.000496	0.00171	CcSEcCtD
Naltrexone—Anorexia—Cisplatin—germ cell cancer	0.000495	0.00171	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000493	0.00171	CcSEcCtD
Naltrexone—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000493	0.0017	CcSEcCtD
Naltrexone—Discomfort—Etoposide—germ cell cancer	0.000491	0.0017	CcSEcCtD
Naltrexone—ABCB1—decidua—germ cell cancer	0.000489	0.00842	CbGeAlD
Naltrexone—Hypersensitivity—Dactinomycin—germ cell cancer	0.000485	0.00168	CcSEcCtD
Naltrexone—Abdominal discomfort—Methotrexate—germ cell cancer	0.000481	0.00166	CcSEcCtD
Naltrexone—Confusional state—Etoposide—germ cell cancer	0.00048	0.00166	CcSEcCtD
Naltrexone—Urticaria—Ifosfamide—germ cell cancer	0.000479	0.00166	CcSEcCtD
Naltrexone—Abdominal pain—Ifosfamide—germ cell cancer	0.000476	0.00165	CcSEcCtD
Naltrexone—Body temperature increased—Ifosfamide—germ cell cancer	0.000476	0.00165	CcSEcCtD
Naltrexone—Anaphylactic shock—Etoposide—germ cell cancer	0.000476	0.00165	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000473	0.00164	CcSEcCtD
Naltrexone—Infection—Etoposide—germ cell cancer	0.000473	0.00164	CcSEcCtD
Naltrexone—Asthenia—Dactinomycin—germ cell cancer	0.000472	0.00163	CcSEcCtD
Naltrexone—Paraesthesia—Cisplatin—germ cell cancer	0.000467	0.00161	CcSEcCtD
Naltrexone—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000466	0.00161	CcSEcCtD
Naltrexone—Tachycardia—Etoposide—germ cell cancer	0.000465	0.00161	CcSEcCtD
Naltrexone—Dyspnoea—Cisplatin—germ cell cancer	0.000463	0.0016	CcSEcCtD
Naltrexone—Skin disorder—Etoposide—germ cell cancer	0.000462	0.0016	CcSEcCtD
Naltrexone—Hyperhidrosis—Etoposide—germ cell cancer	0.00046	0.00159	CcSEcCtD
Naltrexone—Anorexia—Etoposide—germ cell cancer	0.000454	0.00157	CcSEcCtD
Naltrexone—Decreased appetite—Cisplatin—germ cell cancer	0.000452	0.00156	CcSEcCtD
Naltrexone—Diarrhoea—Dactinomycin—germ cell cancer	0.00045	0.00156	CcSEcCtD
Naltrexone—Pneumonia—Methotrexate—germ cell cancer	0.00045	0.00155	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000449	0.00155	CcSEcCtD
Naltrexone—Vomiting—Bleomycin—germ cell cancer	0.000448	0.00155	CcSEcCtD
Naltrexone—Infestation NOS—Methotrexate—germ cell cancer	0.000447	0.00155	CcSEcCtD
Naltrexone—Infestation—Methotrexate—germ cell cancer	0.000447	0.00155	CcSEcCtD
Naltrexone—Depression—Methotrexate—germ cell cancer	0.000446	0.00154	CcSEcCtD
Naltrexone—Rash—Bleomycin—germ cell cancer	0.000445	0.00154	CcSEcCtD
Naltrexone—Pain—Cisplatin—germ cell cancer	0.000444	0.00154	CcSEcCtD
Naltrexone—Dermatitis—Bleomycin—germ cell cancer	0.000444	0.00154	CcSEcCtD
Naltrexone—Hypersensitivity—Ifosfamide—germ cell cancer	0.000444	0.00154	CcSEcCtD
Naltrexone—Conjunctivitis—Methotrexate—germ cell cancer	0.000435	0.0015	CcSEcCtD
Naltrexone—Asthenia—Ifosfamide—germ cell cancer	0.000432	0.0015	CcSEcCtD
Naltrexone—ABCB1—gonad—germ cell cancer	0.000431	0.00741	CbGeAlD
Naltrexone—Feeling abnormal—Cisplatin—germ cell cancer	0.000428	0.00148	CcSEcCtD
Naltrexone—ABCB1—uterus—germ cell cancer	0.000428	0.00736	CbGeAlD
Naltrexone—Paraesthesia—Etoposide—germ cell cancer	0.000427	0.00148	CcSEcCtD
Naltrexone—Pruritus—Ifosfamide—germ cell cancer	0.000426	0.00147	CcSEcCtD
Naltrexone—Dyspnoea—Etoposide—germ cell cancer	0.000424	0.00147	CcSEcCtD
Naltrexone—Somnolence—Etoposide—germ cell cancer	0.000423	0.00146	CcSEcCtD
Naltrexone—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000423	0.00146	CcSEcCtD
Naltrexone—Epistaxis—Methotrexate—germ cell cancer	0.000422	0.00146	CcSEcCtD
Naltrexone—ABCB1—pituitary gland—germ cell cancer	0.00042	0.00723	CbGeAlD
Naltrexone—Nausea—Bleomycin—germ cell cancer	0.000419	0.00145	CcSEcCtD
Naltrexone—Vomiting—Dactinomycin—germ cell cancer	0.000418	0.00145	CcSEcCtD
Naltrexone—Rash—Dactinomycin—germ cell cancer	0.000415	0.00143	CcSEcCtD
Naltrexone—Decreased appetite—Etoposide—germ cell cancer	0.000414	0.00143	CcSEcCtD
Naltrexone—Diarrhoea—Ifosfamide—germ cell cancer	0.000412	0.00143	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000411	0.00142	CcSEcCtD
Naltrexone—Body temperature increased—Cisplatin—germ cell cancer	0.000411	0.00142	CcSEcCtD
Naltrexone—Fatigue—Etoposide—germ cell cancer	0.00041	0.00142	CcSEcCtD
Naltrexone—Constipation—Etoposide—germ cell cancer	0.000407	0.00141	CcSEcCtD
Naltrexone—Pain—Etoposide—germ cell cancer	0.000407	0.00141	CcSEcCtD
Naltrexone—ABCB1—medulla oblongata—germ cell cancer	0.000405	0.00698	CbGeAlD
Naltrexone—Hepatitis—Methotrexate—germ cell cancer	0.000401	0.00139	CcSEcCtD
Naltrexone—Dizziness—Ifosfamide—germ cell cancer	0.000399	0.00138	CcSEcCtD
Naltrexone—Pharyngitis—Methotrexate—germ cell cancer	0.000398	0.00138	CcSEcCtD
Naltrexone—Feeling abnormal—Etoposide—germ cell cancer	0.000392	0.00136	CcSEcCtD
Naltrexone—Nausea—Dactinomycin—germ cell cancer	0.000391	0.00135	CcSEcCtD
Naltrexone—Gastrointestinal pain—Etoposide—germ cell cancer	0.000389	0.00135	CcSEcCtD
Naltrexone—Vomiting—Ifosfamide—germ cell cancer	0.000383	0.00133	CcSEcCtD
Naltrexone—Hypersensitivity—Cisplatin—germ cell cancer	0.000383	0.00132	CcSEcCtD
Naltrexone—Rash—Ifosfamide—germ cell cancer	0.00038	0.00131	CcSEcCtD
Naltrexone—Dermatitis—Ifosfamide—germ cell cancer	0.00038	0.00131	CcSEcCtD
Naltrexone—Urticaria—Etoposide—germ cell cancer	0.000378	0.00131	CcSEcCtD
Naltrexone—Body temperature increased—Etoposide—germ cell cancer	0.000376	0.0013	CcSEcCtD
Naltrexone—Abdominal pain—Etoposide—germ cell cancer	0.000376	0.0013	CcSEcCtD
Naltrexone—ABCB1—adrenal gland—germ cell cancer	0.000375	0.00646	CbGeAlD
Naltrexone—Eye disorder—Methotrexate—germ cell cancer	0.000375	0.0013	CcSEcCtD
Naltrexone—Tinnitus—Methotrexate—germ cell cancer	0.000374	0.00129	CcSEcCtD
Naltrexone—Asthenia—Cisplatin—germ cell cancer	0.000373	0.00129	CcSEcCtD
Naltrexone—Cardiac disorder—Methotrexate—germ cell cancer	0.000373	0.00129	CcSEcCtD
Naltrexone—ABCB1—midbrain—germ cell cancer	0.000371	0.00638	CbGeAlD
Naltrexone—Angiopathy—Methotrexate—germ cell cancer	0.000364	0.00126	CcSEcCtD
Naltrexone—ABCB1—bone marrow—germ cell cancer	0.000363	0.00625	CbGeAlD
Naltrexone—Immune system disorder—Methotrexate—germ cell cancer	0.000363	0.00125	CcSEcCtD
Naltrexone—Mediastinal disorder—Methotrexate—germ cell cancer	0.000362	0.00125	CcSEcCtD
Naltrexone—ABCB1—spinal cord—germ cell cancer	0.000362	0.00622	CbGeAlD
Naltrexone—Chills—Methotrexate—germ cell cancer	0.00036	0.00125	CcSEcCtD
Naltrexone—Nausea—Ifosfamide—germ cell cancer	0.000358	0.00124	CcSEcCtD
Naltrexone—Diarrhoea—Cisplatin—germ cell cancer	0.000356	0.00123	CcSEcCtD
Naltrexone—Alopecia—Methotrexate—germ cell cancer	0.000355	0.00123	CcSEcCtD
Naltrexone—Mental disorder—Methotrexate—germ cell cancer	0.000352	0.00122	CcSEcCtD
Naltrexone—Hypersensitivity—Etoposide—germ cell cancer	0.000351	0.00121	CcSEcCtD
Naltrexone—ABCB1—female gonad—germ cell cancer	0.00035	0.00602	CbGeAlD
Naltrexone—Malnutrition—Methotrexate—germ cell cancer	0.000349	0.00121	CcSEcCtD
Naltrexone—Dysgeusia—Methotrexate—germ cell cancer	0.000342	0.00118	CcSEcCtD
Naltrexone—Asthenia—Etoposide—germ cell cancer	0.000342	0.00118	CcSEcCtD
Naltrexone—Back pain—Methotrexate—germ cell cancer	0.000338	0.00117	CcSEcCtD
Naltrexone—Pruritus—Etoposide—germ cell cancer	0.000337	0.00116	CcSEcCtD
Naltrexone—Vomiting—Cisplatin—germ cell cancer	0.00033	0.00114	CcSEcCtD
Naltrexone—Vision blurred—Methotrexate—germ cell cancer	0.000329	0.00114	CcSEcCtD
Naltrexone—Rash—Cisplatin—germ cell cancer	0.000328	0.00113	CcSEcCtD
Naltrexone—Dermatitis—Cisplatin—germ cell cancer	0.000327	0.00113	CcSEcCtD
Naltrexone—Diarrhoea—Etoposide—germ cell cancer	0.000326	0.00113	CcSEcCtD
Naltrexone—ABCB1—endocrine gland—germ cell cancer	0.000326	0.0056	CbGeAlD
Naltrexone—Ill-defined disorder—Methotrexate—germ cell cancer	0.000324	0.00112	CcSEcCtD
Naltrexone—ABCB1—head—germ cell cancer	0.000321	0.00553	CbGeAlD
Naltrexone—Malaise—Methotrexate—germ cell cancer	0.000315	0.00109	CcSEcCtD
Naltrexone—Dizziness—Etoposide—germ cell cancer	0.000315	0.00109	CcSEcCtD
Naltrexone—ABCB1—testis—germ cell cancer	0.00031	0.00534	CbGeAlD
Naltrexone—Nausea—Cisplatin—germ cell cancer	0.000309	0.00107	CcSEcCtD
Naltrexone—Cough—Methotrexate—germ cell cancer	0.000305	0.00105	CcSEcCtD
Naltrexone—Convulsion—Methotrexate—germ cell cancer	0.000303	0.00105	CcSEcCtD
Naltrexone—Vomiting—Etoposide—germ cell cancer	0.000303	0.00105	CcSEcCtD
Naltrexone—Rash—Etoposide—germ cell cancer	0.0003	0.00104	CcSEcCtD
Naltrexone—Dermatitis—Etoposide—germ cell cancer	0.0003	0.00104	CcSEcCtD
Naltrexone—Headache—Etoposide—germ cell cancer	0.000298	0.00103	CcSEcCtD
Naltrexone—Arthralgia—Methotrexate—germ cell cancer	0.000297	0.00103	CcSEcCtD
Naltrexone—Chest pain—Methotrexate—germ cell cancer	0.000297	0.00103	CcSEcCtD
Naltrexone—Myalgia—Methotrexate—germ cell cancer	0.000297	0.00103	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000295	0.00102	CcSEcCtD
Naltrexone—Discomfort—Methotrexate—germ cell cancer	0.000294	0.00102	CcSEcCtD
Naltrexone—Confusional state—Methotrexate—germ cell cancer	0.000288	0.000994	CcSEcCtD
Naltrexone—ABCB1—cerebellum—germ cell cancer	0.000287	0.00493	CbGeAlD
Naltrexone—Anaphylactic shock—Methotrexate—germ cell cancer	0.000285	0.000986	CcSEcCtD
Naltrexone—Infection—Methotrexate—germ cell cancer	0.000283	0.000979	CcSEcCtD
Naltrexone—Nausea—Etoposide—germ cell cancer	0.000283	0.000978	CcSEcCtD
Naltrexone—Nervous system disorder—Methotrexate—germ cell cancer	0.00028	0.000967	CcSEcCtD
Naltrexone—Skin disorder—Methotrexate—germ cell cancer	0.000277	0.000958	CcSEcCtD
Naltrexone—Hyperhidrosis—Methotrexate—germ cell cancer	0.000276	0.000953	CcSEcCtD
Naltrexone—Anorexia—Methotrexate—germ cell cancer	0.000272	0.00094	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00026	0.000898	CcSEcCtD
Naltrexone—Insomnia—Methotrexate—germ cell cancer	0.000258	0.000892	CcSEcCtD
Naltrexone—Paraesthesia—Methotrexate—germ cell cancer	0.000256	0.000885	CcSEcCtD
Naltrexone—Dyspnoea—Methotrexate—germ cell cancer	0.000254	0.000879	CcSEcCtD
Naltrexone—Somnolence—Methotrexate—germ cell cancer	0.000254	0.000876	CcSEcCtD
Naltrexone—Decreased appetite—Methotrexate—germ cell cancer	0.000248	0.000857	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000246	0.000851	CcSEcCtD
Naltrexone—Fatigue—Methotrexate—germ cell cancer	0.000246	0.00085	CcSEcCtD
Naltrexone—Pain—Methotrexate—germ cell cancer	0.000244	0.000843	CcSEcCtD
Naltrexone—Feeling abnormal—Methotrexate—germ cell cancer	0.000235	0.000812	CcSEcCtD
Naltrexone—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000233	0.000806	CcSEcCtD
Naltrexone—ABCB1—brain—germ cell cancer	0.000233	0.00401	CbGeAlD
Naltrexone—Urticaria—Methotrexate—germ cell cancer	0.000227	0.000783	CcSEcCtD
Naltrexone—Abdominal pain—Methotrexate—germ cell cancer	0.000225	0.000779	CcSEcCtD
Naltrexone—Body temperature increased—Methotrexate—germ cell cancer	0.000225	0.000779	CcSEcCtD
Naltrexone—ABCB1—lymph node—germ cell cancer	0.000225	0.00387	CbGeAlD
Naltrexone—Hypersensitivity—Methotrexate—germ cell cancer	0.00021	0.000726	CcSEcCtD
Naltrexone—Asthenia—Methotrexate—germ cell cancer	0.000205	0.000707	CcSEcCtD
Naltrexone—Pruritus—Methotrexate—germ cell cancer	0.000202	0.000698	CcSEcCtD
Naltrexone—Diarrhoea—Methotrexate—germ cell cancer	0.000195	0.000675	CcSEcCtD
Naltrexone—Dizziness—Methotrexate—germ cell cancer	0.000189	0.000652	CcSEcCtD
Naltrexone—Vomiting—Methotrexate—germ cell cancer	0.000181	0.000627	CcSEcCtD
Naltrexone—Rash—Methotrexate—germ cell cancer	0.00018	0.000622	CcSEcCtD
Naltrexone—Dermatitis—Methotrexate—germ cell cancer	0.00018	0.000621	CcSEcCtD
Naltrexone—Headache—Methotrexate—germ cell cancer	0.000179	0.000618	CcSEcCtD
Naltrexone—Nausea—Methotrexate—germ cell cancer	0.000169	0.000586	CcSEcCtD
